FIELD: medicine.
SUBSTANCE: invention relates to the field of medicine, in particular to the blood testing, and can be used to Von Willebrand disease diagnostics. Method for Von Willebrand disease (subtype 2N) diagnostics consists in using thromboelastography before and after a two-fold infusion of the Von Willebrand factor (WF) concentrate at a dose of 40–50 IU/kg to detect this subtype, and the diagnosis is performed by determining Ratio score as the ratio of the blood recalcification time (when recording a thromboelastogram), before a two-fold infusion to the time of blood recalcification after a two-fold infusion of WF concentrate, and with a ratio score greater than 1.3, Von Willebrand disease (subtype 2N) is diagnosed.
EFFECT: method for Von Willebrand disease diagnostics is proposed.
1 cl, 2 dwg, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR IMMUNOENZYME ANALYSIS FOR ASSAY OF VON WILLEBRAND FACTOR, MONOCLONAL ANTIBODY TO VON WILLEBRAND FACTOR (VARIANTS) AND STRAIN OF HYBRID CULTURED MAMMAL CELLS MUS MUSCULUS L - PRODUCER OF MONOCLONAL ANTIBODIES TO VON WILLEBRAND FACTOR (VARIANTS) | 2004 |
|
RU2271010C2 |
| METHOD FOR DETECTING HEPARIN IN BLOOD | 2017 |
|
RU2662171C1 |
| METHOD FOR PREVENTION OF HEMORRHAGIC COMPLICATIONS IN PATIENTS WITH VON WILLEBRAND DISEASE DURING IN VITRO FERTILIZATION | 2023 |
|
RU2816883C1 |
| METHOD FOR ASSESSING HEMOSTATIC ACTIVITY | 2015 |
|
RU2601111C1 |
| METHOD OF PREDICTING CHARACTER OF PROGRESSING COURSE OF CHRONIC KIDNEY DISEASE | 2010 |
|
RU2430364C1 |
| METHOD FOR IDENTIFYING BLOOD HYPERCOAGULATION | 1991 |
|
RU2015515C1 |
| METHOD OF ESTIMATING CONDITION OF BLOOD COAGULATION SYSTEM IN PATIENTS IN CRITICAL CONDITION | 2012 |
|
RU2517116C2 |
| METHOD FOR DETERMINATION OF FUNCTIONAL FIBRINOGEN | 2017 |
|
RU2669796C1 |
| TREATMENT OF COAGULATION DISORDERS BY ADMINISTRATION OF RECOMBINANT WILLEBRAND FACTOR | 2019 |
|
RU2787855C2 |
| TREATMENT OF COAGULATION DISEASE BY ADMINISTRATION OF RECOMBINANT vWF | 2012 |
|
RU2628537C2 |
